Answer
Vyndaqel 20 mg soft capsules containing tafamidis meglumine are contraindicated in patients with hypersensitivity to the active substance or any excipient listed in section 6.1.
Sources for this answer
- Vyndaqel 20 mg soft capsulesPfizer Limited · emc · SmPC §4.3 Contraindications · Version 18Document updated
Sources checked